Oncolytic viruses for cancer immunotherapy

被引：0
|
作者：
Otto Hemminki
João Manuel dos Santos
Akseli Hemminki
机构：
[1] University Health Network and University of Toronto,Division of Urologic Oncology, Department of Surgical Oncology, Princess Margaret Cancer Centre
[2] University of Helsinki,Cancer Gene Therapy Group, Translational Immunology Research Program
[3] Helsinki University Hospital,Department of Urology
[4] TILT Biotherapeutics Ltd,undefined
[5] Helsinki University Hospital Comprehensive Cancer Center,undefined
来源：
Journal of Hematology & Oncology | / 13卷
关键词：
Adenovirus; Oncolytic; Tumor; Cancer; Immunotherapy; Review; Immunology; Immune system; Immunosupression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In this review, we discuss the use of oncolytic viruses in cancer immunotherapy treatments in general, with a particular focus on adenoviruses. These serve as a model to elucidate how versatile viruses are, and how they can be used to complement other cancer therapies to gain optimal patient benefits. Historical reports from over a hundred years suggest treatment efficacy and safety with adenovirus and other oncolytic viruses. This is confirmed in more contemporary patient series and multiple clinical trials. Yet, while the first viruses have already been granted approval from several regulatory authorities, room for improvement remains.
引用
收藏
相关论文
共 50 条
  • [21] A review exploring the fusion of oncolytic viruses and cancer immunotherapy: An innovative strategy in the realm of cancer treatment
    Chattopadhyay, Soumyadeep
    Hazra, Rudradeep
    Mallick, Arijit
    Gayen, Sakuntala
    Roy, Souvik
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (04):
  • [22] Oncolytic viruses against cancer, promising or delusion?
    Arash Letafati
    Omid Salahi Ardekani
    Mina Naderisemiromi
    Mohammad Mehdi Fazeli
    Nillofar Asadi Jemezghani
    Jila Yavarian
    Medical Oncology, 40
  • [23] Oncolytic viruses: finally delivering
    Seymour, Leonard W.
    Fisher, Kerry D.
    BRITISH JOURNAL OF CANCER, 2016, 114 (04) : 357 - 361
  • [24] Immunologic Mechanisms and Clinical Research Progress of Oncolytic Viruses
    Yang Hao
    Zhang Shao-Geng
    Yang Peng-Hui
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2022, 49 (08) : 1398 - 1405
  • [25] Development of a New Hyaluronic Acid Based Redox-Responsive Nanohydrogel for the Encapsulation of Oncolytic Viruses for Cancer Immunotherapy
    Deng, Siyuan
    Iscaro, Alessandra
    Zambito, Giorgia
    Mijiti, Yimin
    Minicucci, Marco
    Essand, Magnus
    Lowik, Clemens
    Muthana, Munitta
    Censi, Roberta
    Mezzanotte, Laura
    Di Martino, Piera
    NANOMATERIALS, 2021, 11 (01) : 1 - 20
  • [26] Solid Tumor Immunotherapy with T Cell Engager-Armed Oncolytic Viruses
    Scott, Eleanor M.
    Duffy, Margaret R.
    Freedman, Joshua D.
    Fisher, Kerry D.
    Seymour, Leonard W.
    MACROMOLECULAR BIOSCIENCE, 2018, 18 (01)
  • [27] Targeting Autophagy for Oncolytic Immunotherapy
    Hu, Lulu
    Ke, Jiang
    Chan, Ding
    Meng, Songshu
    BIOMEDICINES, 2017, 5 (01)
  • [28] Oncolytic Immunotherapy
    Hennessy, Morgan L.
    Bommareddy, Praveen K.
    Boland, Genevieve
    Kaufman, Howard L.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 28 (03) : 419 - +
  • [29] Evolution of oncolytic viruses: novel strategies for cancer treatment
    Atherton, Matthew J.
    Lichty, Brian D.
    IMMUNOTHERAPY, 2013, 5 (11) : 1191 - 1206
  • [30] Combination therapy with oncolytic viruses for lung cancer treatment
    Sun, Lei
    Zhao, Qi
    Miao, Liyun
    FRONTIERS IN ONCOLOGY, 2025, 15
12345